Copyright
©The Author(s) 2022.
World J Psychiatry. Apr 19, 2022; 12(4): 623-635
Published online Apr 19, 2022. doi: 10.5498/wjp.v12.i4.623
Published online Apr 19, 2022. doi: 10.5498/wjp.v12.i4.623
No. | Ref./country
| Tumor site | Number of participants/gender/age in years | Time since diagnosis | Parameters and tests (related to psychiatric disorders) | Key results: Prevalence of clinical levels of: Anxiety/depression/PTSD/comorbid anxiety-depression | Possible bias |
1 | Alexander et al[26], 2010; United Kingdom | Breast | n = 200; 100% female; mean: 58.1, range: 29-89 | Mean time since last treatment: 10.1 mo | EDS; HADS; SCID | Depression: 9%; anxiety: 3.5%; comorbid: 1.5 | Selection bias; response bias |
2 | Amir et al[28], 2002; Israel | Breast | n = 39; 100% female; range: 37-60 | ≥ 5 yr | PTSD-scale; SCL-90 | Full PTSD: 18%; partial PTSD: 56% (additional) | Selection bias; response bias |
3 | Mehnert et al[25], 2008; Germany | Breast | n = 1083; 100% female; mean: 61.8, range: 31-81 | Average: 47 mo | HADS; PCL-C | Moderate to high anxiety: 38% (high: 20.1%); moderate to high depression: 22% (high: 11.3%); PTSD: 12% | Selection bias; response bias |
4 | Qiu et al[42], 2012; China | Breast | n = 505; 100% female; mean: 52.02 | Mean time after surgery: 17.6 mo | BDI; MINI | Depression: 20.59% | Response bias; performance bias |
5 | Vazquez et al[16], 2020; United States | Breast | n = 700; 100% female; median: 37, range: 17-40 | 144 d: HADS; 30 mo (PCL-S) | PCL-S; HADS | PTSS: 6.3%; depression: 8%; anxiety: 23% | Selection bias; response bias |
6 | Dahl et al[24], 2005; Norway | Testicular | n = 1408; 100% male; mean: 44.6 | Mean: 11.3 yr | HADS | Anxiety: 19.2%; depression: 9.7%; comorbid: 6.8% | Selection bias; response bias |
7 | Dahl et al[17], 2016; Norway | Testicular | n = 1418; 100% male; mean: 44.6 | Mean: 11 yr | IES | Full PTSD: 4.5%; partial PTSD: 6.4%; probable PTSD (combination of the 2): 10.9% | Selection bias; response bias |
8 | Fosså et al[43], 2003; Norway | Testicular | n = 791; 100% male; median: 44, range: 23-75 | Median: 12 yr | HADS | Anxiety: 19%; depression: 9% | Selection bias; response bias |
9 | Thorsen et al[15], 2005; Norway | Testicular | n = 1260; 100% male; median: 42 | Mean: 11 years | HADS | Anxiety: 20.2%; depression 9.7% | Selection bias; response bias |
10 | Vehling et al[19], 2016; Germany | Testicular | n = 164; 100% male; mean: 44.4 | Mean: 11.6 yr | GAD-7; PHQ-9 | Anxiety: 6.1%; depression: 7.9% | Selection bias; response bias |
11 | Chen et al[33], 2013; United States | Head and neck | n = 211; 58% male; median: 57, range: 21-93 | Disease free at least 1 yr | UW-QOL | Depression: 17% | Response bias |
12 | Lambert et al[21], 2005; United States | Head and neck | n = 694; 84.6% male; mean: 61.8 | At least 6 mo | GDS-SF | Depression: 44.1% | Selection bias; response bias |
13 | Moschopoulou et al[44], 2018; United Kingdom | Head and neck | n = 93; 58.1% male; mean: 66 | Mean: 6 yr | PCL-C | PTSD: 11.8% | Selection bias; response bias |
14 | Black et al[45], 2005; United Kingdom | Hodgkin’s lymphoma non- Hodgkin’s lymphoma; acute leukemia | n = 36; 50% female; adults | ? - complete remission | PCL-C | PTSD: 17% | Selection bias; response bias |
15 | Daniëls et al[46], 2014; The Netherlands | Hodgkin’s lymphoma | n = 180; 55% male; median: 46 | Mean: 4.6 yr | HADS | Anxiety: 23%; depression: 18% | Selection bias; response bias |
16 | Geffen et al[35], 2003; Israel | Hodgkin’s lymphoma; non-Hodgkin’s lymphoma | HD: n = 8; nHL: n = 36; 46% male; median: 51; range: 27-80 | At least 2 yr after treatment completion | PTSD-inventory scale | Full or partial PTSD: 32%; full PTSD: 18%; partial PTSD: 13% (additional) | Selection bias; response bias |
17 | Kuba et al[47], 2019; Germany | Hematological | n = 922; 57% male; range: 18-85 | 3 yr | PHQ-9; GAD-7 | Anxiety: 9%; depression: 15% | Selection bias; response bias |
18 | Han et al[22], 2013; Korea | Stomach | n = 391; 72.9% male; mean: 54.5 | Mean (time since operation): 27.4 mo | BDI | Depression: 43.9% | Selection bias; response bias |
19 | Hanprasertpong et al[48], 2017; Thailand | Cervical | n = 700; 100% female; mean: 53 | Completion of treatment 3 mo - 10 yr before study | HADS | Anxiety: 20.46%; depression: 9.44% | Selection bias; response bias |
20 | Urbaniec et al[18], 2011; Australia | Gynecological | n = 45; 100% female; mean: 56.7, range: 23-83 | Mean: 4 yr; range: 0.9-11.6 yr | BDI-II; SAI; IES-Revised | Anxiety: 28.9%; depression: 20%; probable PTSD: 15.6 | Selection bias; response bias |
21 | Krajewski et al[49], 2018; Germany | Melanoma | n = 561; 51.2% male; mean: 62.1 | 4 yr | HADS | Anxiety: 10.2%; depression: 10.3% | Selection bias; response bias |
22 | Rogiers et al[27], 2020; Belgium | Melanoma | n =25; 28% male; median: 58, range: 28-86 | Median: 30 mo | SCID-IV-CV; HADS | HADS: Anxiety: 32%; depression: 20%; comorbid: 12%. SCID: PTSD: 48%; depression: 0% | Selection bias; response bias; performance bias |
23 | Rogiers et al[14], 2020; Belgium | Melanoma | n = 17; 29% male; median: 57, range: 33-86 | Median: 5.6 yr | SCID-IV-CV; HADS | HADS: Anxiety: 35%; depression: 41%; comorbid: 30%. Interview: PTSD: 35%; depression: 11.76% | Selection bias; response bias; performance bias |
24 | Nicol et al[23], 2019; Australia | Brain | n = 65; 35.4% male; mean: 49.97; range: 22-75 | Mean: 5.29 yr | DASS-Depression; GAD-7 | Anxiety: 58.5%; depression: 43.1% | Selection bias; response bias |
25 | Recklitis et al[50], 2014; United States | Prostate | n = 693; 100% male; mean: 67.1 | Range: 3-8 yr | GDS-15 | Depression: 15% | Selection bias; response bias |
26 | Uchitomi et al[51], 2003; Japan | Lung | n = 212; 60.4% male; mean: 62.1, range: 22-83 | 1 mo after surgery | SCID, Revised; POMS scale | Depression: 8% | Selection bias; performance bias |
- Citation: Bach A, Knauer K, Graf J, Schäffeler N, Stengel A. Psychiatric comorbidities in cancer survivors across tumor subtypes: A systematic review. World J Psychiatry 2022; 12(4): 623-635
- URL: https://www.wjgnet.com/2220-3206/full/v12/i4/623.htm
- DOI: https://dx.doi.org/10.5498/wjp.v12.i4.623